IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q3 2022 Holdings

Filed 2022-11-14 | 12 holdings | $110.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bellus Health Inc New(BLU)COM NEW07987C204$25.2K2,382,12722.7%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$22.0K3,056,42019.8%
Kinnate Biopharma IncCOM49705R105$20.0K1,674,67718.1%
Merus N VCOMN5749R100$12.3K613,07111.1%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$8.1K2,325,8337.3%
Aerovate Therapeutics IncCOM008064107$4.6K276,4474.1%
Pardes Biosciences IncCOM69945Q105$4.2K2,275,7323.8%
Pieris Pharmaceuticals IncCOM720795103$4.0K3,515,1403.6%
Passage BIO IncCOM702712100$3.4K2,752,4223.1%
Immunic Inc(IMUX)COM4525EP101$3.4K1,072,2883.1%
Theseus Pharmaceuticals IncCOM88369M101$2.9K504,8622.6%
Otonomy IncCOM68906L105$6822,312,8800.6%